U.S. News & World Report: A patient's guide to norovirus
UC expert provides risk factors of contracting norovirus
Carl Fichtenbaum, MD, professor in the Division of Infectious Diseases in the Department of Internal Medicine at the UC College of Medicine was featured in an article in U.S. News & World Report on norovirus. Fichtenbaum provided five risk factors for norovirus, a virus that causes nausea, vomiting and diarrhea. They include:
- eating contaminated food,
- drinking contaminated water,
- contact with a person who's infected with norovirus,
- having a serious medical condition, like cancer, that compromises your immune system
- and spending time with large numbers of people in a confined space, such as in a nursing home, on a cruise ship, in a hotel or at a resort.
Read the article here.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.